Julie Carr Smyth and Geoff Mulvihill, Associated Press Updated 8:54 pm CDT, Friday, July 19, 2019 FILE - This Monday, June 17, 2019, file photo, shows 5-mg pills of Oxycodone. Two Ohio counties are asking a judge to find that drugmakers and distributors were not allowed to ship suspicious orders of controlled substances to pharmacies. If a judge sides with the request from Cuyahoga and Summit counties, it would clear the way for the governments to assert that drug companies ignored the regulations as a nationwide opioid crisis continued to grow. less FILE - This Monday, June 17, 2019, file photo, shows 5-mg pills of Oxycodone. Two Ohio counties are asking a judge to find that drugmakers and distributors were not allowed to ship suspicious orders of ... more Photo: Keith Srakocic, AP Photo: Keith … [Read more...] about Counties: Drug companies shipped suspicious opioid orders
Drug company galashiels
For two decades, as 200,000 opioid overdose deaths piled up across America, there was always someone else to blame. Families blamed drug companies. Drug companies blamed doctors. Everyone blamed the government. More than half the public continues to see drug addiction as a moral failing, blaming substance abusers themselves for the epidemic, at least in part, according to recent polling.OxyContin pills arranged for a photo at a pharmacy. Maine is among many states that have sued Connecticut-based Purdue Pharma, maker of OxyContin, alleging the legal opioids have fueled drug addiction problems. Toby Talbot/Associated Press file photo But now the effort to hold someone to account for the deadliest drug crisis in U.S. history is narrowing to a few dozen drug companies whose day in court has come or will soon arrive. Virtually every state and nearly 2,000 towns, cities and counties have demanded those firms, which include some of America’s most trusted brands, be forced to pay up … [Read more...] about Lawyers zero in on drug companies amid opioid epidemic
1 of 11 View 11 Items Kristin Murphy, Deseret News Dr. Norman L. Foster, Center for Alzheimer's Care, Imaging and Research director, shows what parts of the brain correspond to an amyloid PET scan showing Alzheimer's plaque pathology in a patient with memory loss at the University of Utah's Center for Alzheimer's Care, Imaging and Research in Salt Lake City on Tuesday, June 18, 2019. Related Links She has Alzheimer's. He has a girlfriend. Is he committing adultery? Lois Collins: What happened to the promising progress on fighting Alzheimer's? This new test for Alzheimer's is like playing a video game. Here's how it works SALT LAKE CITY — The last drug approved to treat Alzheimer's disease went on sale in 2003, and a handful of highly anticipated and promising phase-three clinical trials for other drug treatments recently bombed. The road to a cure for Alzheimer's is lined with bruised drug companies — and now, some big players … [Read more...] about What happens if big drug companies drop Alzheimer’s research?
NORMAN – Johnson & Johnson, one of the nation’s best-known brands and developers of prescription pain medications, ignored history, turned a blind eye to evidence that pills like oxycodone were dangerously addictive and prioritized profits over people, creating a multibillion-dollar mess in Oklahoma the company should be made to clean up, attorneys for the state said Tuesday. The state of Oklahoma’s case against Johnson & Johnson, the first in a string of civil trials anticipated across the nation and stemming from the opioid epidemic, opened in Cleveland County District Court with about four hours of opening statements, first by Attorney General Mike Hunter and three other lawyers for the state and followed by J&J attorney Larry Ottaway. The trial in the courtroom of District Judge Thad Balkman has drawn media attention from around the world. Reporters from PBS, the Wall Street Journal and 60 Minutes were among those who filled 18 rows in the … [Read more...] about State claims drug company put profits over people
opinion Dave Robertson Published 11:00 PM EDT May 19, 2019 Momentum has been building in Washington to take action on out-of-control prescription drug prices. One in four Americans cannot afford their medication, creating a full-fledged crisis that can no longer be ignored. Lawmakers on both sides of the aisle vowed to hold Big Pharma accountable in the 116th Congress. Already this year, several hearings have taken place on Capitol Hill to address out-of-control drug prices — an optimistic sign that concrete action is beginning to take shape. The Trump administration pledged to lower prescription drug prices, too. The administration has made some laudable proposals and efforts. It aims to increase transparency in the drug market by forcing drug manufacturers to include a drug’s list price in their direct-to-consumer ads. The FDA, under outgoing Commissioner Scott Gottlieb, has worked to bolster competition and call out abuses in the marketplace by cracking down on … [Read more...] about Opinion: Rebate Rule bails out drug companies